Patents by Inventor Tami Bar

Tami Bar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240408182
    Abstract: The present invention provides a pharmaceutical composition containing 10 mg to about 100 g KRED and/or a long-acting alcohol dehydrogenase as an active ingredient and a pharmaceutically acceptable carrier. Moreover, provided herein methods for lowering blood alcohol level, methods for preventing a symptom or a risk arising from alcohol consumption and methods for treating a subject afflicted with alcoholism by the administration of the pharmaceutical composition of the invention.
    Type: Application
    Filed: August 21, 2024
    Publication date: December 12, 2024
    Inventors: Tami BAR, Thomas KOEVARY
  • Publication number: 20220047682
    Abstract: The present invention provides a pharmaceutical composition containing 10 mg to about 100 g KRED and/or a long-acting alcohol dehydrogenase as an active ingredient and a pharmaceutically acceptable carrier. Moreover, provided herein methods for lowering blood alcohol level, methods for preventing a symptom or a risk arising from alcohol consumption and methods for treating a subject afflicted with alcoholism by the administration of the pharmaceutical composition of the invention.
    Type: Application
    Filed: October 24, 2019
    Publication date: February 17, 2022
    Inventors: Tami BAR, Thomas KOEVARY
  • Publication number: 20210275556
    Abstract: Embodiments of the invention are directed to formulations comprising Cannabidiol (CBD) and glucosamine (Gln). Further embodiments of the invention are directed to methods of treating or preventing Arthritis, Osteoarthritis, Rheumatoid arthritis, Osteoporosis, Osteopenia, jaw pain, joint pain, knee pain, back pain, multiple sclerosis, Osteomalacia and Paget's disease of bone, wherein the method comprises administering a formulation comprising Cannabidiol (CBD) and glucosamine (Gln).
    Type: Application
    Filed: July 1, 2019
    Publication date: September 9, 2021
    Applicant: Companion Sciences. LLC
    Inventors: Golan VAKNIN, Tami Bar